Cognitive rehabilitation therapy in patients with somatic symptom and related disorders.
Completed
- Conditions
- somatic symptom and related disorder10077546
- Registration Number
- NL-OMON50112
- Lead Sponsor
- GGZ instellingen / Psychiatrische Ziekenhuizen
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 40
Inclusion Criteria
patients with SSRD, >= 18 years, cognitive symptoms.
Exclusion Criteria
direct risk of suicide, dementia, usage of illicit drugs
within the past 6 months, consumption of more than 21 units of alcohol per
week, illiteracy, insufficient knowledge of Dutch language or short-term risk
of psychoses, and refusal to informed consent .
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The primary outcome of this study is subjective cognitive functioning as<br /><br>measured by the Cognitive Faillure Questionnaire (CFQ) (Broadbent,Cooper,<br /><br>FitzGerald & Parkes, 1982). The CFQ is a self-report questionnaire related to<br /><br>everyday cognitive failure/misstakes related to cognitive functioning. The<br /><br>questionnaire consists of 25 items which are measured using a 5-point scale (0<br /><br>= never, 4=always). The CFQ has good psychometric properties, include<br /><br>test-retest reliability (Ponds, van Boxtel & Jolles, 2006) and reliability<br /><br>(Bridger, Johnsen& Brasher, 2013). Higher scores are indicative for more<br /><br>subjective congitive symptoms. The CFQ-scores are measured before, during (6<br /><br>weeks) and after treamtnt to evaluate the course of cognitive functioning<br /><br>during therapy. </p><br>
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie cognitive rehabilitation therapy for somatic symptom disorders?
How effective is cognitive rehabilitation therapy compared to standard care in somatic symptom disorder patients?
Are there specific biomarkers that predict response to cognitive rehabilitation therapy in somatic symptom disorders?
What adverse events are associated with cognitive rehabilitation therapy for somatic symptom and related disorders?
What are the potential combination approaches for cognitive rehabilitation therapy in somatic symptom disorders?